Accelerating microbiota product development: The Societal Impact Value Cycle as a conceptual model to shape and improve public-private valorization processes

Wine’s Phenolic Compounds and Health: A Pythagorean View

“…We retrieved 24 publications of human studies that employed dealcoholized wine ( Table S1 ). Taken together, their results indicate that wine (poly)phenols do exert healthful effects, ranging from anti-inflammatory actions to modulation of the microbiota, which is now gaining traction from an industrial viewpoint [ 78 , 79 ] and might be one of the next applications of these compounds. The extent and precise nature of such activities, however, remains to be fully elucidated.…”

Synthetic consortia of nanobody‐coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis‐associated diseases and co‐morbidities

“…Timmis and Timmis, 2017), (ii) a shift towards more appropriate financing mechanisms (e.g. combined push-and pull-incentives) to streamline translation and trialling of promising novel interventions (Renwick and Mossialos, 2018), and (iii) utilization of knowledge valorization models to reduce information asymmetries between stakeholders and, in turn, improve the prospects of commercialising relevant new knowledge generated in public and private research and development organizations (Van de Burgwal et al, 2018).…”

A critical appreciation of intangible resources in PharmaNutrition

“…At the same time, analyses of industry-specific innovation barriers and technological lifecycles have shown that novel approaches to ensure competitive advantage-built upon an appreciation of intangible resources-are necessary to bring the field forward [21][22][23]. As we have previously shown however, such approaches are not clear-cut; innovation barriers result from a lack of understanding and appreciation, and therefore a lack of proper consideration of intangible resources relevant for stakeholders in the society and market domains, which appear consistently underrepresented in academic innovation literature [24,25]. Technological advances and radical innovations in the sharing of information and resources between the various stakeholders in this process can only partially accommodate for this neglect [26].…”

“…Indeed, industries that have adopted a strategic approach to intangible resources, like the organoids industry, have combined technological disruptions with incredible market successes [28,31]. Thus, a thorough understanding of how these intangible resources relate to innovation processes and their success criteria in the pharmanutrition industry is needed to contribute to enhanced innovation performance, addressing unmet societal needs with improved efficiency [24,[32][33][34].…”